| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |